Part D Senior Savings Model: What is it?

If you are on Medicare, how much will you pay for insulin? The answer is in the graph below (via MedPAC’s Payment Basics) Seem confusing? Well it is. Medicare Part D beneficiaries have a deductible, then the standard coverage phase with 25% cost sharing, then a coverage gap where beneficiaries pay 25% of cost (manufacturers …

Part D Senior Savings Model: What is it? Read More »

HLTH 2021: Reimbursement Flexibility Is Key to Digital Health Innovation

With the pandemic came a need to reach more patients remotely than ever before. To address this need, Congress passed the Coronavirus Aid, Relief and Economic Security Act, which granted authority for the Centers for Medicare & Medicaid Services (CMS) to provide flexibility for Medicare telehealth services through waivers. This flexibility led to increased adoption …

HLTH 2021: Reimbursement Flexibility Is Key to Digital Health Innovation Read More »

Veta Health Apoints CEO, Walgreens Leadership Appointments, Walmart’s New VP, Other Executive Appointments

James Sutcliffe, CEO at Veta Health Veta Health, a global provider of digital solutions for remote patient care and chronic condition monitoring appoints James Sutcliffe has been named chief executive officer. Sutcliffe will guide the strategic direction of the company with an emphasis on key commercial dynamics. Founders Tanvi Vattikuti Abbhi and Dr. Nora Zetsche …

Veta Health Apoints CEO, Walgreens Leadership Appointments, Walmart’s New VP, Other Executive Appointments Read More »

Already allied with Takeda, Egle raises €40M for its ‘starving’ immunotherapy

In less than two years, Egle Therapeutics launched, partnered with Takeda Pharmaceutical, and found its first cancer targets. Now the startup has €40M in Series A financing to further develop its new approach to modulating regulatory T cells as a way of treating autoimmune diseases and cancer.

23andMe Acquires Lemonaid Health for $400M – Health M&A

What You Should Know: – Consumer genetics and research company 23andMe, today announced a definitive merger agreement with Lemonaid Health, Inc., an on-demand platform for accessing medical care and pharmacy services online. – As part of the merger agreement, 23andMe acquired Lemonaid Health for $400M, of which 25% will be paid in cash and 75% in …

23andMe Acquires Lemonaid Health for $400M – Health M&A Read More »

The “Secret Sauce” – A Comparison of TSMC and Pfizer

By MIKE MAGEE This week’s Tom Friedman Opinion piece in the New York Times contained a title impossible to ignore: “China’s Bullying Is Becoming a Danger To The World and Itself.” The editorial has much to recommend it. But the item that caught my eye was Friedman’s full-throated endorsement of Taiwan’s “most sophisticated microchip manufacturer in the …

The “Secret Sauce” – A Comparison of TSMC and Pfizer Read More »

Hitachi, Tohoku University and Kyoto University Become World’s First to Establish Technology for Highly Efficient Production of Actinium-225

TOKYO, Hitachi, Ltd. (TSE: 6501), Tohoku University and Kyoto University have become the world’s first (1) to establish technology for the highly efficient and high-quality production of actinium-225 (225Ac), a substance required for a form of radiation therapy known as targeted alpha therapy (TAT). TAT is a new cancer therapy which combines a substance that …

Hitachi, Tohoku University and Kyoto University Become World’s First to Establish Technology for Highly Efficient Production of Actinium-225 Read More »

Launch of world-first expert resource to foster best practice osteoporosis care in the Asia Pacific

New Delhi, India, More than 50 per cent of the world’s hip fractures are expected to occur in the Asia Pacific by the year 2050. In a strong effort to stem the tide, and to promote quality care in osteoporosis, the Asia Pacific Consortium on Osteoporosis (APCO) has launched a world-first, interactive, educational osteoporosis resource …

Launch of world-first expert resource to foster best practice osteoporosis care in the Asia Pacific Read More »

5 things about Babylon’s $460M merger

The AI-powered telehealth software joined Alkuri Global Acquisition Corp. in the latest special purpose acquisition corporation merger.

Agilex Biolabs Shares How to Select the Right Bioanalytical Tools for Immuno-oncology and Vaccines Studies – OCT Webinar

ADELAIDE, AUS, Oct 19, 2021 – (ACN Newswire) – Agilex Biolabs, the Australian regulated bioanalytical and toxicology laboratory facilities for clinical trials is presenting a new webinar entitled “Getting it right! Considerations for Immuno-oncology and Vaccine Studies and the Bioanalytical Tools used” in partnership with Outsourcing Clinical Trials (OCT). Agilex Biolabs’ Director, Immunoassay, Kurt J. Sales (B.Sc; B.Sc (MED) …

Agilex Biolabs Shares How to Select the Right Bioanalytical Tools for Immuno-oncology and Vaccines Studies – OCT Webinar Read More »

“Este es el último pañal que me queda”: la ansiedad de ser padres en la pobreza

Para los padres que viven en la pobreza, la “matemática del pañal” es un cálculo diario, apremiante y angustiante, con el que están familiarizados. En los Estados Unidos, los bebés usan de seis a 10 pañales desechables al día, a un costo promedio de $70 a $80 al mes. Los pañales de marca con alta …

“Este es el último pañal que me queda”: la ansiedad de ser padres en la pobreza Read More »

Cerner to lay off 150 workers next month

New Cerner CEO Dr. David Feinberg, who took the helm as company CEO on Oct. 1, sent an email to staff Thursday informing them about the upcoming layoffs, a Cerner spokesperson confirmed to Modern Healthcare.

Funny memes may have helped people cope with stress of pandemic: study

Funny memes may have helped people cope with the stress of the coronavirus pandemic, a study published by the American Psychological Association found.The researchers found that those who viewed memes, especially those with a higher “cuteness” level…

Here’s Why Developing Countries Can Make the Top Covid Vaccines

Pfizer and Moderna are skeptical, but we found 10 companies in Africa, Asia and South America well-positioned to produce the gold-standard mRNA shots.

Let the Booster Mixing Begin

Mixing and matching vaccine brands is officially on the table in the United States. But that option might soon be billed as the B-list choice. Last night, CDC Director Rochelle Walensky gave the green light for Moderna and Johnson & Johnson booster shots, the long-awaited follow-up to a similar recommendation given to the Pfizer formulation …

Let the Booster Mixing Begin Read More »

Confronting Ageism in Health Care: A Conversation for Patients, Caregivers and Clinicians

Can’t see the video player? View the video here. What does ageism in health care look like? It can be a thoughtless quip that makes an older person feel diminished. Or an assumption that patients are unable to follow a conversation or make their own decisions. Maybe it occurs when a concern is voiced, then …

Confronting Ageism in Health Care: A Conversation for Patients, Caregivers and Clinicians Read More »

Alembic Pharmaceuticals Ltd-Pre-Planned Open Interviews for Freshers On 24th Oct’ 2021

Alembic Pharmaceuticals Ltd-Pre-Planned Open Interviews for Freshers On 24th Oct’ 2021 Job Description Alembic Pharmaceuticals Ltd. is an Indian multinational pharmaceutical company headquartered in Vadodara city of Gujarat-India. Alembic Pharmaceuticals Ltd is involved in manufacture of pharmaceutical products, pharmaceutical substances and intermediates. •We have career opportunities for Freshers @ API & Injectable manufacturing site at …

Alembic Pharmaceuticals Ltd-Pre-Planned Open Interviews for Freshers On 24th Oct’ 2021 Read More »

Cellectis Opens GMP Manufacturing Facility

A new GMP facility in Raleigh, NC, and a starting materials facility in Paris, France, give Cellectis end-to-end, in-house manufacturing capacity for its UCART product candidates.

SAP launches a Lighten the Load programme to help employees manage MSDs

Back to news 22/10/2021 SAP launches a Lighten the Load programme to help employees manage MSDs Official campaign Partner SAP has rolled out a toolkit for its employees, providing information, tips and good practice advice on managing musculoskeletal disorders (MSDs) and on what they can do to lighten their own load.See more

PharmaShots Weekly Snapshots (October 18 – 22, 2021)

LEO Reports 16-week Results of Tralokinumab in P-III ECZTRA 6 Trial for the Treatment of Moderate-to-Severe Atopic Dermatitis Published: 22 Oct, 2021 | Tags: LEO, Tralokinumab, P-III, ECZTRA 6 Trial, Atopic Dermatitis Marinomed Biotech Signs a License Agreement with Luoxin to Commercialize Budesolv (budesonide nasal spray) in Greater China Published: 22 Oct, 2021 | Tags: …

PharmaShots Weekly Snapshots (October 18 – 22, 2021) Read More »

Pfizer says COVID-19 vaccine more than 90% effective in kids

Kid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S. considers opening vaccinations to that age group.

Pfizer says COVID vaccine nearly 91 percent effective in younger kids

Smaller doses of Pfizer’s COVID-19 vaccine for children ages 5 to 11 appear safe and are nearly 91 percent effective at preventing symptomatic disease, the company said in a study released Friday.Pfizer’s study was released ahead of a pivotal Food…

LEO Reports 16-week Results of Tralokinumab in P-III ECZTRA 6 Trial for the Treatment of Moderate-to-Severe Atopic Dermatitis

Shots: The P-III ECZTRA 6 trial evaluates the efficacy & safety of tralokinumab (150/300mg, q2w) as monothx. vs PBO in 301 patients aged 12-17yrs. with mod. to sev. AD who were candidates for systemic therapy The trial met its 1EPs & 2EPs i.e., @16wks., patients achieved a clinical response & achieved clear or almost clear …

LEO Reports 16-week Results of Tralokinumab in P-III ECZTRA 6 Trial for the Treatment of Moderate-to-Severe Atopic Dermatitis Read More »

Marinomed Biotech Signs a License Agreement with Luoxin to Commercialize Budesolv (budesonide nasal spray) in Greater China

Shots: Marinomed to receive $2M up front & is eligible to receive milestones upon achievement of development, regulatory & commercial milestones along with royalties on sales of Budesolv in Greater China Luoxin will co-develop Budesolv, a new formulation of the glucocorticoid budesonide in China & will lead the clinical development & obtain the Chinese marketing …

Marinomed Biotech Signs a License Agreement with Luoxin to Commercialize Budesolv (budesonide nasal spray) in Greater China Read More »

Dupixent scores a first in rare skin disease prurigo nodularis

Sanofi and Regeneron’s Dupixent has become the first biologic drug to show activity in prurigo nodularis (PN), raising the hope of a new treatment option for the rare and highly debilitating skin disease. The two companies are still waiting for the results of a second phase 3 trial, due in the first half of next …

Dupixent scores a first in rare skin disease prurigo nodularis Read More »

Regeneron and Sanofi Report Results of Dupixent (dupilumab) in P-III PRIME2 Trial for the Treatment of Prurigo Nodularis

Shots: The P-III PRIME2 trial evaluates Dupixent vs PBO with/out topical treatments in 160 adults with PN inadequately controlled with topical prescription therapies The trial met its 1EPs and all key 2EPs i.e., patients experienced a reduction in itch from baseline (37% vs 22%) @12wks.; reduction in itch from baseline (58% vs 20%) & patients …

Regeneron and Sanofi Report Results of Dupixent (dupilumab) in P-III PRIME2 Trial for the Treatment of Prurigo Nodularis Read More »

Health Innovators: Healios’ Richard Andrews

In the latest Health Innovators video chat, pharmaphorum’s founder, Dr Paul Tunnah, chats with the founder and CEO of digital mental health pioneer Healios. Rich Andrews explains his background in big pharma and his inspiration for moving into the start-up space with Healios and its focus on mental health and neurodiverse conditions for children and …

Health Innovators: Healios’ Richard Andrews Read More »

BMS strikes back against Merck in EU oesophageal cancer market

Merck & Co’s Keytruda become the first cancer immunotherapy to be approved as a first-line oesophageal cancer treatment in the EU earlier this year, but will now face competition from Bristol-Myers Squibb’s Opdivo. The European Commission has given a green light to Opdivo (nivolumab) with chemotherapy for previously-untreated patients with HER2-negative oesophageal, gastric and gastroesophageal …

BMS strikes back against Merck in EU oesophageal cancer market Read More »

Acceleron investors dig their heels in on Merck takeover bid

Activist investors are pushing back against Merck & Co’s recent $11.5 billion deal to acquire Acceleron Pharma, arguing that its $180-per-share offer seriously undervalues the company. Avoro Capital, Holocene Advisors and Darwin Global are all arguing that Acceleron should hold off on a sale for several upcoming developments that they maintain could dramatically increase vale. …

Acceleron investors dig their heels in on Merck takeover bid Read More »

How are the European pharma and biotech sectors addressing strategic communications?

Stakeholder expectations are high and, with all eyes on healthcare at the moment, it is essential for companies to go beyond generic commitments, says Rosanna Campbell-Gray. Consumers are driving and accelerating change when it comes to healthcare, demanding better, faster and more accessible services. The COVID-19 pandemic has further altered the dynamics for this sector …

How are the European pharma and biotech sectors addressing strategic communications? Read More »

‘No Mercy’ Bonus Episodes: More From Fort Scott, Kansas

Searching for the Nuns Who Ghosted Fort Scott Host Sarah Jane Tribble sets out on a mission to learn more about the Sisters of Mercy, the nuns who founded Fort Scott’s Mercy Hospital and were once prominent leaders of the community. Tribble’s first glimpse into their lives takes her to an old convent. To learn …

‘No Mercy’ Bonus Episodes: More From Fort Scott, Kansas Read More »

‘Down to My Last Diaper’: The Anxiety of Parenting in Poverty

For parents living in poverty, “diaper math” is a familiar and distressingly pressing daily calculation. Babies in the U.S. go through six to 10 disposable diapers a day, at an average cost of $70 to $80 a month. Name-brand diapers with high-end absorption sell for as much as a half a dollar each, and can …

‘Down to My Last Diaper’: The Anxiety of Parenting in Poverty Read More »

Montana Tribes Want to Stop Jailing People for Suicide Attempts but Lack a Safer Alternative

POPLAR, Mont. — When Maria Vega was a senior in high school in 2015, she found the body of one of her closest friends, who had died by suicide. A few days later, devastated by the loss, Vega tried to take her own life. After the attempt failed, she was arrested and taken to juvenile …

Montana Tribes Want to Stop Jailing People for Suicide Attempts but Lack a Safer Alternative Read More »

FDA clears AI-powered digital test for early dementia

The FDA has approved an artificial intelligence-based test for early detection of dementia that can be carried out on an iPad in five minutes. The CognICA Integrated Cognitive Assessment (ICA) test developed by London, UK-based company Cognetivity Neurosciences has been approved by the FDA as an alternative to traditional pen-and-paper tests with some key advantages, …

FDA clears AI-powered digital test for early dementia Read More »

Scynexis Reports Results of Ibrexafungerp in P-III VANISH-303 Trial for Treatment of Vaginal Yeast Infection

Shots: The P-III VANISH-303 evaluates ibrexafungerp vs PBO in patients with VVC & P-II DOVE studies assess ibrexafungerp vs fluconazole for the same indication. The results were published in America’s Clinical Infectious Diseases In the P-III study, the therapy was superior in completely resolving signs & symptoms of VVC @10 Day (50.5% vs 28.6%); superior …

Scynexis Reports Results of Ibrexafungerp in P-III VANISH-303 Trial for Treatment of Vaginal Yeast Infection Read More »

Selecta Enters into an Exclusive License Agreement with Genovis to Advance IgG Protease in Gene Therapy and Autoimmune Disease

Shots: Genovis to receive up front for an exclusive license to Xork & is eligible to receive development & sales-based milestones along with royalties on sales globally & holds the rights for research, preclinical, diagnostic & other non-therapeutic applications of Xork The collaboration will utilize Genovis’ IgG protease, IdeXork (Xork & Selecta’s ImmTOR platform for …

Selecta Enters into an Exclusive License Agreement with Genovis to Advance IgG Protease in Gene Therapy and Autoimmune Disease Read More »

Incyte Enters into a Supply Agreement with Specialised Therapeutics to Launch Tafasitamab and Pemigatinib in Australia and Other Countries

Shots: Incyte will lead the development, manufacture, and supply of both products. ST will be responsible for the regulatory, distribution, and local marketing related activities in Australia, New Zealand & Singapore Tafasitamab + lenalidomide is approved in the US & EU to treat adult patients with r/r DLBCL who are not eligible for ASCT Pemigatinib …

Incyte Enters into a Supply Agreement with Specialised Therapeutics to Launch Tafasitamab and Pemigatinib in Australia and Other Countries Read More »

CMMI and its revised strategy

Created by Section 3021 of the Affordable Care Act (ACA), the Centers for Medicare and Medicaid Innovation (CMMI; aka The CMS Innovation Center) has been tasked with creating new reimbursement strategies to improve quality and decrease costs. Over the past decade, CMMI has tested over 50 new payment models, and in just the last 3 …

CMMI and its revised strategy Read More »

FDA Approves Another Interchangeable Biosimilar Drug

By Kevin E. Noonan — On October 15th, the Food and Drug Administration approved its second interchangeable biosimilar drug. That drug is Cyltezo (adalimumab-adbm), produced by Boehringer Ingelheim, which obtained biosimilar approval on August 25, 2017. In this recent approval, the FDA determined that Cyltezo is interchangeable with AbbVie’s Humira (adalimumab), its reference product. Cyltezo …

FDA Approves Another Interchangeable Biosimilar Drug Read More »

How Employee-Focused Tech Can Help Hospitals Endure the Latest COVID Surge

Anna Nerz, Healthcare Solution Manager at SAP For hospitals and the people who staff them, it was exactly the déjà vu they were hoping to avoid: another surge in COVID-19 cases, with the now all-too-familiar strains and stressors that accompany it. The rapid spread of the Delta variant in the U.S. and elsewhere brought reports …

How Employee-Focused Tech Can Help Hospitals Endure the Latest COVID Surge Read More »

Akums Drugs & Pharmaceuticals Ltd- Walk-In Interview for QC On 23rd October 2021

Akums Drugs & Pharmaceuticals Ltd- Walk-In Interview for QC On 23rd October 2021 Job Description Walk-In Interview for QC Department @ Akums Drugs & Pharmaceuticals Ltd Department: QC Qualification: : B.Sc /B.Pharm/ M.Sc Experience:  1 to 4 years Location: Chandigarh (Derabassi Plant Date: 23rd October 2021 Time: 10:00 AM to 01:00 PM Venue: Akums Life Sciences Ltd, Vill.-Sundran, Mubarikpur Road, Derabassi You can …

Akums Drugs & Pharmaceuticals Ltd- Walk-In Interview for QC On 23rd October 2021 Read More »

Biocon Biologics- Walk- In Interview for Warehouse Department On 23rd October 2021

Biocon Biologics- Walk- In Interview for Warehouse Department On 23rd October 2021 Job Description We are Conducting a walk-in Drive On 23rd October 2021 Skill Sets: •Relevant experience in Warehouse Operations , Receipts, Storage & Dispensing to Production, QMS Documentation Procedures •Knowledge of CGMP, GDP,QMS & EHS practices. •Ensure proper storage , Housekeeping, Equipment Calibration …

Biocon Biologics- Walk- In Interview for Warehouse Department On 23rd October 2021 Read More »

ReCode Therapeutics gets $80M to deliver on new RNA therapies for the lungs

ReCode Therapeutics closed an $80 million Series B round of financing that included Pfizer and Sanofi as investors. The startup’s technology uses lipid nanoparticles to deliver genetic medicines, and its two lead programs are for rare lung disorders.

Massachusetts hospital workers lose bid on vaccine mandate

A federal judge denied a request by several employees at the largest hospital system in Massachusetts for an injunction to block the company from placing them on unpaid leave for violating the system’s COVID-19 vaccine mandate.

Zerigo Health Raises $43M, Appoints Glen Tullman as Executive Chairman

What You Should Know: – Today, Zerigo Health, a San Diego, CA-based connected light therapy solution for treating chronic skin conditions at home or on the go, today announced a $43M Series B funding round led by 7wireVentures, joined by General Catalyst, Dragoneer, Cigna Ventures, Leverage Health Solutions, and Leaps by Bayer. – In addition, …

Zerigo Health Raises $43M, Appoints Glen Tullman as Executive Chairman Read More »

Oak Street Health Acquires RubiconMD for $130M – Health M&A

RubiconMD Co-founders Carlos Reines (left) and Gil Addo (right) What You Should Know: – Oak Street Health, Inc., a network of value-based primary care centers for adults on Medicare, today announced it has acquired RubiconMD, the leading technology platform providing access to specialist expertise. – Motivated by their own experiences within the healthcare system, CEO …

Oak Street Health Acquires RubiconMD for $130M – Health M&A Read More »

German officials tussle over lifting COVID-19 state of emergency

Bavarian Minister Markus Söder said Thursday that Germany should keep its COVID-19 state of emergency as new virus cases rise again, Reuters reported. During an appearance on a local radio station, Söder said that if Germany’s state of…

CMS Launches ‘One-Stop Shop’ for States’ HCBS Investment Plans

The U.S. Centers for Medicare & Medicaid Services (CMS) on Thursday launched a “one-stop shop” for state Medicaid agencies and in-home care stakeholders. The goal of the new digital tool is to “advance transparency and innovation” for home- and community-based services (HCBS), according to the agency. The one-stop shop specifically offers detailed information on how …

CMS Launches ‘One-Stop Shop’ for States’ HCBS Investment Plans Read More »

Humana’s Retail President: Kindred at Home Acquisition Will Transform the Health Care Ecosystem

Close to 90% of older adults want to receive care in their homes as they age, according to a study conducted earlier this year by the AP-NORC Center for Public Affairs Research. But outside of just aging in place in general, during the COVID-19 crisis, individuals of all ages have also become more aware of …

Humana’s Retail President: Kindred at Home Acquisition Will Transform the Health Care Ecosystem Read More »

GOP senators call on Biden to back down from vaccine mandates

A group of Republican senators on Thursday sent a letter to the White House calling on President Biden to back down from his COVID-19 vaccine mandate policies.The senators, led by Dan Sullivan (R-Alaska) and Tommy Tuberville (R-Ala.), said the…

LHC Group CEO Keith Myers: Choose Home Winning Capitol Hill Support, But SNF Stakeholders Still Need Convincing

Since its introduction in the U.S. Senate in July, the Choose Home Care Act of 2021 has been a hot topic among home health leaders. Most have overwhelmingly embraced the legislation as a major step forward for home-based care. One of these leaders is none other than Keith Myers, chairman and CEO of LHC Group …

LHC Group CEO Keith Myers: Choose Home Winning Capitol Hill Support, But SNF Stakeholders Still Need Convincing Read More »

Improve patients’ outcomes with AI-powered remote monitoring devices and increase revenue for your practice [Sponsored]

A webinar from MedCity News sponsored by 100Plus scheduled for November 9 at 12pm ET will explore remote patient monitoring to achieve greater patient adherence and clinically meaningful outcomes for conditions such as hypertension, obesity, and diabetes. 

HLTH 2021: Partnerships and Interoperability Are Key to Microsoft’s Healthcare Strategy

The pandemic has had a major impact on priorities in healthcare, accelerating digital health adoption and innovation. The industry had to pivot quickly, and Microsoft has pivoted with it as the company expands its partnerships in healthcare. In a HLTH 2021 session titled “How Microsoft is Enabling the Next Generation of Patient Care and Collaboration,” …

HLTH 2021: Partnerships and Interoperability Are Key to Microsoft’s Healthcare Strategy Read More »

Regeneration in the Central Nervous System: Hold It, Hold It, Hold It!

We have news that gives us something to think about, in this era of genetic reprogramming, cell therapy, viral vectors and all the other extraordinary technologies that we’re bringing to bear on intractable diseases. There has been a lot of work in recent years on trying to induce regenerative processes in various tissues that don’t …

Regeneration in the Central Nervous System: Hold It, Hold It, Hold It! Read More »

KHN’s ‘What the Health?’: Dems Agree to Agree, But Not on What to Agree On

Can’t see the audio player? Click here to listen on Acast. You can also listen on Spotify, Apple Podcasts, Stitcher, Pocket Casts or wherever you listen to podcasts. Negotiations over what to include in — and cut from — the domestic spending package on Capitol Hill are reportedly making progress, but so far all Democrats …

KHN’s ‘What the Health?’: Dems Agree to Agree, But Not on What to Agree On Read More »

THCB Gang Episode 69 – Thurs October 21 — Alex Drane Special 10am PT- 1pm ET

I am so thrilled that as part of my East coast jaunt I get to do another special #THCBGang. This one is with the amazing Alex Drane. Who among other things has almost singlehandedly changed the conversation about SDOH and lots more in this country. And you know that’s true because Jeff Goldsmith ahs said …

THCB Gang Episode 69 – Thurs October 21 — Alex Drane Special 10am PT- 1pm ET Read More »

The Benefits of a Pre-Training Shake

Post-workout protein intake has numerous benefits. For a long time, fitness experts and nutritionists have recommended taking protein after your workout. Though the health benefits of pre-workout protein intake are in question, the post-workout protein intake helps recover muscle after intense exercise. A pre-training shake is a drink that you can consume before any workout …

The Benefits of a Pre-Training Shake Read More »

KFF Global COVID-19 Coverage Tool: Current and Projected Coverage – Updated as of October 21

This interactive tool, which will be updated regularly, provides the share of the population that has received at least one dose of a COVID-19 vaccine by income-level, region, country, and globally. Additionally, using current rates of first dose administration, the tool estimates whether projected coverage levels will meet certain global targets.

Using Microanalysis in Pharmaceutical Product Development v2

This application note demonstrates the importance of maintaining strict quality control of pharmaceuticals – from raw and packaging materials to intermediate and final products that are completely free of contaminants.

Expert panel takes up complicated COVID-19 booster questions

The advisers to the CDC are slated to discuss who should get extra doses of the Moderna or Johnson & Johnson vaccines — and the bigger question of getting a different brand for the booster than people’s original vaccination.